-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Nabriva Therapeutics plc quarterly/annual Costs and Expenses history and growth rate from 2017 to 2022.
- Nabriva Therapeutics plc Costs and Expenses for the quarter ending June 30, 2023 was $14.3M, a 27.2% decline year-over-year.
- Nabriva Therapeutics plc Costs and Expenses for the twelve months ending June 30, 2023 was $83.6M, a 3.21% increase year-over-year.
- Nabriva Therapeutics plc annual Costs and Expenses for 2022 was $92.4M, a 19.4% increase from 2021.
- Nabriva Therapeutics plc annual Costs and Expenses for 2021 was $77.4M, a 8.81% increase from 2020.
- Nabriva Therapeutics plc annual Costs and Expenses for 2020 was $71.2M, a 20% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)